Novel Food or Not? Checking Supplement Ingredients Before Launch in the EU

Novel Food or Not? How to Check Your Ingredient

An ingredient that was not used for human consumption to a significant degree in the EU before 15 May 1997 is a novel food, and cannot be placed on the market until it is authorised. For supplement developers, who often reach for new botanicals, extracts and isolated compounds, this is the most important ingredient question to settle before launch.

What makes an ingredient novel

The test is history of consumption, not safety. Under the EU novel foods framework, a food or ingredient with no significant use in the EU before the May 1997 cut-off needs a pre-market authorisation, whether it is a plant extract, a new production process outcome or a newly isolated substance. Authorised novel foods are recorded in a Union list that sets conditions of use, specifications and labelling.

How to find out where you stand

  • Novel Food Catalogue: the Commission maintains an informal, regularly updated catalogue of the status of many foods and ingredients. It is a useful first screen, but it is not legally binding.
  • Consultation with a Member State: a business unsure of status can request a determination from the Member State where it plans to market. National authorities such as Ireland’s FSAI describe a decision period of four months, extendable to eight, with decisions published on the Commission website.
  • Evidence file: collect documented consumption data, with dates and quantities, for the ingredient and the form you intend to use. The same plant can be traditional as a tea and novel as a concentrated extract.

If it is novel

A business that wants to place a novel food on the EU market for the first time submits an application to the European Commission through its e-submission system, and EFSA carries out the safety assessment. This is a multi-year investment, so the commercial case should be tested early, and alternatives with an established history of use considered.

Why this matters for supplements in Greece and Cyprus

A supplement notified or licensed in Greece or Cyprus must still comply with EU novel food law. A national notification does not authorise an ingredient that the EU framework treats as novel, and an authority can challenge the product after launch.

Practical steps

  • Screen every ingredient and extract against the catalogue at formulation stage.
  • Record the exact form, part of plant and extraction method used.
  • Request a Member State determination when the evidence is mixed.
  • Keep the outcome in the compliance file for each market.

How PQRA helps

PQRA screens supplement formulations for novel food status, assembles consumption evidence, supports consultation requests and advises on the path to authorisation where an ingredient proves to be novel.

Contact PQRA to check your ingredients before launch

Tags:

No responses yet

Αφήστε μια απάντηση

Η ηλ. διεύθυνση σας δεν δημοσιεύεται. Τα υποχρεωτικά πεδία σημειώνονται με *